Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Lung Neoplasms"" wg kryterium: Temat


Tytuł:
Lung cancer screening provider recommendation and completion in black and White patients with a smoking history in two healthcare systems: a survey study.
Autorzy:
Japuntich SJ; Hennepin Healthcare, 730 South 8th St., Minneapolis, MN, 55415, USA. .; Hennepin Healthcare Research Institute, 701 Park Ave., PP7.700, Minneapolis, MN, 55415, USA. .; Department of Medicine, University of Minnesota Medical School, 401 East River Parkway, VCRC 1st Floor, Suite 131, Minneapolis, MN, 55455, USA. .
Walaska K; The Miriam Hospital, Coro Center West, 1 Hoppin St., Suite 309, Providence, RI, 02903, USA.
Friedman EY; Hennepin Healthcare Research Institute, 701 Park Ave., PP7.700, Minneapolis, MN, 55415, USA.
Balletto B; The Miriam Hospital, Coro Center West, 1 Hoppin St., Suite 309, Providence, RI, 02903, USA.
Cameron S; Hennepin Healthcare Research Institute, 701 Park Ave., PP7.700, Minneapolis, MN, 55415, USA.
Tanzer JR; Rhode Island Hospital, 130 Plain St., Providence, RI, 02903, USA.
Fang P; Hennepin Healthcare Research Institute, 701 Park Ave., PP7.700, Minneapolis, MN, 55415, USA.
Clark MA; Brown University School of Public Health, One Davol Square, 121 South Main St, Providence, RI, 02903, USA.
Carey MP; Department of Psychiatry and Human Behavior, Brown University, 75 Waterman St, Providence, RI, 02912, USA.
Fava J; The Miriam Hospital, Coro Center West, 1 Hoppin St., Suite 309, Providence, RI, 02903, USA.
Busch AM; Hennepin Healthcare, 730 South 8th St., Minneapolis, MN, 55415, USA.; Hennepin Healthcare Research Institute, 701 Park Ave., PP7.700, Minneapolis, MN, 55415, USA.; Department of Medicine, University of Minnesota Medical School, 401 East River Parkway, VCRC 1st Floor, Suite 131, Minneapolis, MN, 55455, USA.
Breault C; The Miriam Hospital, Coro Center West, 1 Hoppin St., Suite 309, Providence, RI, 02903, USA.
Rosen R; The Miriam Hospital, Coro Center West, 1 Hoppin St., Suite 309, Providence, RI, 02903, USA.; Brown University School of Public Health, One Davol Square, 121 South Main St, Providence, RI, 02903, USA.
Pokaż więcej
Źródło:
BMC primary care [BMC Prim Care] 2024 Jun 07; Vol. 25 (1), pp. 202. Date of Electronic Publication: 2024 Jun 07.
Typ publikacji:
Journal Article
MeSH Terms:
Black or African American*/statistics & numerical data
Early Detection of Cancer*
Lung Neoplasms*/epidemiology
Lung Neoplasms*/ethnology
Lung Neoplasms*/diagnosis
Smoking*/epidemiology
White*/statistics & numerical data
Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Colorectal Neoplasms/diagnosis ; Colorectal Neoplasms/ethnology ; Colorectal Neoplasms/epidemiology ; Surveys and Questionnaires ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł:
Exploring shared decision-making needs in lung cancer screening among high-risk groups and health care providers in China: a qualitative study.
Autorzy:
Lin X; School of Nursing, Fujian Medical University, No 1, Xueyu Road, Minhou county, Fujian, Fuzhou, 350108, China.
Wang F; School of Nursing, Fujian Medical University, No 1, Xueyu Road, Minhou county, Fujian, Fuzhou, 350108, China.
Li Y; School of Nursing, Fujian Medical University, No 1, Xueyu Road, Minhou county, Fujian, Fuzhou, 350108, China.
Lei F; School of Nursing, University of Minnesota, Twin Cities, Minneapolis, MN, USA.
Chen W; Department of Thoracic Oncology Surgery, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.
Arbing RH; School of Nursing, University of California Los Angeles, Los Angeles, CA, 90095, USA.
Chen WT; School of Nursing, University of California Los Angeles, Los Angeles, CA, 90095, USA. .
Huang F; School of Nursing, Fujian Medical University, No 1, Xueyu Road, Minhou county, Fujian, Fuzhou, 350108, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 May 21; Vol. 24 (1), pp. 613. Date of Electronic Publication: 2024 May 21.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/diagnosis
Lung Neoplasms*/diagnostic imaging
Decision Making, Shared*
Early Detection of Cancer*/psychology
Early Detection of Cancer*/methods
Qualitative Research*
Health Personnel*/psychology
Humans ; Male ; Female ; China ; Middle Aged ; Aged ; Tomography, X-Ray Computed/methods ; Adult ; Patient Participation
Czasopismo naukowe
Tytuł:
Development of the Korean Association for Lung Cancer Clinical Practice Guidelines: Recommendations on Radial Probe Endobronchial Ultrasound for Diagnosing Lung Cancer - An Updated Meta-Analysis.
Autorzy:
Kim SH; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
Chung HS; Division of Pulmonology, National Cancer Center, Goyang, Korea.
Kim J; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.; Department of Biostatistics, Pusan National University Hospital, Busan, Korea.
Kim MH; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
Lee MK; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
Kim I; Department of Internal Medicine, Dong-A University Hospital, Busan, Korea.
Eom JS; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2024 Apr; Vol. 56 (2), pp. 464-483. Date of Electronic Publication: 2023 Nov 29.
Typ publikacji:
Systematic Review; Meta-Analysis; Journal Article
MeSH Terms:
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Humans ; Bronchoscopy/methods ; Retrospective Studies ; Biopsy ; Republic of Korea ; Lung/diagnostic imaging ; Lung/pathology
Czasopismo naukowe
Tytuł:
Efficacy and safety of concurrent immune checkpoint inhibitors combined with radiotherapy or chemoradiotherapy for advanced non-small cell lung cancer: A systematic review and single-arm meta-analysis.
Autorzy:
Cui R; Department of Oncology, The First People's Hospital of Neijiang, Neijiang, Sichuan, China.
Li Y; Department of Oncology, The First People's Hospital of Neijiang, Neijiang, Sichuan, China.
Yu X; Department of Oncology, The Second People's Hospital of Neijiang, Neijiang, Sichuan, China.
Wei C; Department of Oncology, The Second People's Hospital of Neijiang, Neijiang, Sichuan, China.
Jiang O; Department of Oncology, The First People's Hospital of Neijiang, Neijiang, Sichuan, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jun 12; Vol. 19 (6), pp. e0304941. Date of Electronic Publication: 2024 Jun 12 (Print Publication: 2024).
Typ publikacji:
Journal Article; Systematic Review; Meta-Analysis
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/therapy
Carcinoma, Non-Small-Cell Lung*/pathology
Carcinoma, Non-Small-Cell Lung*/drug therapy
Immune Checkpoint Inhibitors*/therapeutic use
Immune Checkpoint Inhibitors*/adverse effects
Lung Neoplasms*/therapy
Lung Neoplasms*/pathology
Lung Neoplasms*/drug therapy
Chemoradiotherapy*/adverse effects
Chemoradiotherapy*/methods
Humans ; Progression-Free Survival ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Prognostic factors and nomogram for pulmonary resected high-grade neuroendocrine carcinomas: a 20-year single institutional real-world experience.
Autorzy:
Liu L; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, P. R. China.
Zhang J; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, P. R. China.
Zhao K; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, P. R. China.
Guo C; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, P. R. China.
Huang C; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, P. R. China.
Li S; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, P. R. China.
Chen Y; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, P. R. China. .
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2024 Jun 12; Vol. 19 (1), pp. 232. Date of Electronic Publication: 2024 Jun 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Neuroendocrine*/surgery
Carcinoma, Neuroendocrine*/pathology
Carcinoma, Neuroendocrine*/mortality
Nomograms*
Lung Neoplasms*/surgery
Lung Neoplasms*/pathology
Lung Neoplasms*/mortality
Humans ; Female ; Male ; Middle Aged ; Retrospective Studies ; Prognosis ; Aged ; Adult ; Aged, 80 and over
Czasopismo naukowe
Tytuł:
Correlation of CT features of lung adenocarcinoma with sex and age.
Autorzy:
Yang Y; Department of Radiology, Huadong Hospital, Fudan University, Shanghai, 200040, China.
Gao Y; Department of Radiology, Huadong Hospital, Fudan University, Shanghai, 200040, China.
Lu F; Department of Radiology, Huadong Hospital, Fudan University, Shanghai, 200040, China.
Wang E; Department of Radiology, Huadong Hospital, Fudan University, Shanghai, 200040, China.
Liu H; Department of Radiology, Huadong Hospital, Fudan University, Shanghai, 200040, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jun 11; Vol. 14 (1), pp. 13414. Date of Electronic Publication: 2024 Jun 11.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/pathology
Tomography, X-Ray Computed*
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Lung Neoplasms*/genetics
Humans ; Male ; Female ; Middle Aged ; Aged ; Age Factors ; Retrospective Studies ; Sex Factors ; Adult ; Aged, 80 and over ; ErbB Receptors/genetics
Czasopismo naukowe
Tytuł:
Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy.
Autorzy:
Shan J; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, Shangcheng District, China. .; Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China. .
Liu Z; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, Shangcheng District, China.; Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
Chen S; Department of Medicine, Burning Rock Biotech, Guangzhou, China.
Du C; Department of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, Shangcheng District, China.
Li B; Department of Medicine, Burning Rock Biotech, Guangzhou, China.
Ruan L; Department of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Kong M; Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wang L; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, Shangcheng District, China.; Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
Du M; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, Shangcheng District, China.; Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
Shi S; Data Science Department, Burning Rock Biotech, Guangzhou, China.
Qiao G; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, Shangcheng District, China.; Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
Tian T; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, Shangcheng District, China.; Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
Tu Z; Department of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, Shangcheng District, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Jun 10; Vol. 22 (1), pp. 234. Date of Electronic Publication: 2024 Jun 10.
Typ publikacji:
Journal Article; Clinical Trial, Phase II
MeSH Terms:
Lung Neoplasms*/drug therapy
Lung Neoplasms*/pathology
Antibodies, Monoclonal, Humanized*/therapeutic use
Antibodies, Monoclonal, Humanized*/administration & dosage
Antineoplastic Combined Chemotherapy Protocols*/therapeutic use
Antineoplastic Combined Chemotherapy Protocols*/administration & dosage
Humans ; Male ; Middle Aged ; Female ; Aged ; Carboplatin/administration & dosage ; Carboplatin/therapeutic use ; Paclitaxel/administration & dosage ; Paclitaxel/therapeutic use ; Neoplasm Staging ; Perioperative Care/methods ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/pathology ; Treatment Outcome ; Adult ; Carcinoma, Squamous Cell/drug therapy ; Carcinoma, Squamous Cell/pathology
Czasopismo naukowe
Tytuł:
HTR2B as a novel biomarker of chronic obstructive pulmonary disease with lung squamous cell carcinoma.
Autorzy:
Li Y; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
Wang Y; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
Wu R; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
Li P; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China. .
Cheng Z; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jun 08; Vol. 14 (1), pp. 13206. Date of Electronic Publication: 2024 Jun 08.
Typ publikacji:
Journal Article
MeSH Terms:
Pulmonary Disease, Chronic Obstructive*/genetics
Pulmonary Disease, Chronic Obstructive*/metabolism
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Lung Neoplasms*/metabolism
Biomarkers, Tumor*/genetics
Biomarkers, Tumor*/metabolism
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/pathology
Carcinoma, Squamous Cell*/metabolism
Epithelial-Mesenchymal Transition*/genetics
Humans ; Receptor, Serotonin, 5-HT2B/genetics ; Receptor, Serotonin, 5-HT2B/metabolism ; Gene Expression Regulation, Neoplastic ; Cell Proliferation/genetics ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Developing a prognostic model using machine learning for disulfidptosis related lncRNA in lung adenocarcinoma.
Autorzy:
Pan Y; Department of Pulmonary Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.; Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, China.
Jin X; Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Xu H; Department of Pulmonary Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.; Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, China.
Hong J; Department of Pulmonary Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.; School of Medicine, Shaoxing University, Shaoxing, China.
Li F; Department of Pulmonary Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China. .
Luo T; Department of Pulmonary Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China. .
Zeng J; Department of Pulmonary Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jun 07; Vol. 14 (1), pp. 13113. Date of Electronic Publication: 2024 Jun 07.
Typ publikacji:
Journal Article
MeSH Terms:
RNA, Long Noncoding*/genetics
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Adenocarcinoma of Lung*/mortality
Machine Learning*
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Lung Neoplasms*/mortality
Humans ; Prognosis ; Gene Expression Regulation, Neoplastic ; Biomarkers, Tumor/genetics ; Tumor Microenvironment/genetics ; ROC Curve ; Kaplan-Meier Estimate
Czasopismo naukowe
Tytuł:
Investigating socioeconomic disparities in lung cancer diagnosis, treatment and mortality: an Italian cohort study.
Autorzy:
Servadio M; Department of Epidemiology, Regional Health Service Lazio, Rome, Italy.
Rosa AC; Department of Epidemiology, Regional Health Service Lazio, Rome, Italy. .
Addis A; Department of Epidemiology, Regional Health Service Lazio, Rome, Italy.
Kirchmayer U; Department of Epidemiology, Regional Health Service Lazio, Rome, Italy.
Cozzi I; Department of Epidemiology, Regional Health Service Lazio, Rome, Italy.
Michelozzi P; Department of Epidemiology, Regional Health Service Lazio, Rome, Italy.
Cipelli R; IQVIA Solutions Srl, Milan, Italy.
Heiman F; IQVIA Solutions Srl, Milan, Italy.
Davoli M; Department of Epidemiology, Regional Health Service Lazio, Rome, Italy.
Belleudi V; Department of Epidemiology, Regional Health Service Lazio, Rome, Italy.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Jun 07; Vol. 24 (1), pp. 1543. Date of Electronic Publication: 2024 Jun 07.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Lung Neoplasms*/mortality
Lung Neoplasms*/diagnosis
Lung Neoplasms*/therapy
Healthcare Disparities*/statistics & numerical data
Socioeconomic Factors*
Humans ; Italy ; Male ; Female ; Retrospective Studies ; Aged ; Middle Aged ; Aged, 80 and over ; Socioeconomic Disparities in Health
Czasopismo naukowe
Tytuł:
Oncolytic adenovirus encoding LHPP exerts potent antitumor effect in lung cancer.
Autorzy:
Zhao Y; College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.; Oncology Department, Zhejiang Xiaoshan HospitaI, Hangzhou, China.
Liu H; College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Zhan Q; College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Jin H; College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Wang Y; Surgical Department of Duchang County Second People's Hospital, Jiujiang, 332600, China.
Wang H; Oncology Department, Zhejiang Xiaoshan HospitaI, Hangzhou, China.
Huang B; College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Huang F; Department of Pathology, Zhejiang Provincial People's Hospital, Hangzhou, 310014, China.
Jia X; College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China. .
Wang Y; College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China. .
Wang X; Oncology Department, Zhejiang Xiaoshan HospitaI, Hangzhou, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jun 07; Vol. 14 (1), pp. 13108. Date of Electronic Publication: 2024 Jun 07.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Oncolytic Virotherapy*/methods
Adenoviridae*/genetics
Oncolytic Viruses*/genetics
Xenograft Model Antitumor Assays*
Apoptosis*
Humans ; Animals ; Mice ; Cell Line, Tumor ; Cell Proliferation ; Mice, Nude ; Female ; Autophagy
Czasopismo naukowe
Tytuł:
Caspase-4 promotes metastasis and interferon-γ-induced pyroptosis in lung adenocarcinoma.
Autorzy:
Chiba Y; Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.; Department of Molecular Biology, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Doi T; Department of Molecular Biology, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Obayashi K; Department of Molecular Biology, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Sumida K; Department of Molecular Biology, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Nagasaka S; Department of Molecular Biology, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Wang KY; Shared-Use Research Center, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Yamasaki K; Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Masago K; Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan.
Matsushita H; Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Kuroda H; Department of Surgery, Teikyo University Mizonokuchi Hospital, Kawasaki, Japan.
Yatera K; Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Endo M; Department of Molecular Biology, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2024 Jun 07; Vol. 7 (1), pp. 699. Date of Electronic Publication: 2024 Jun 07.
Typ publikacji:
Journal Article
MeSH Terms:
Pyroptosis*
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Adenocarcinoma of Lung*/metabolism
Interferon-gamma*/metabolism
Interferon-gamma*/pharmacology
Interferon-gamma*/genetics
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Lung Neoplasms*/metabolism
Caspases, Initiator*/metabolism
Caspases, Initiator*/genetics
Animals ; Humans ; Mice ; Cell Line, Tumor ; Neoplasm Metastasis ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Tytuł:
POLR1D silencing suppresses lung cancer cells proliferation and migration via inhibition of PI3K-Akt pathway.
Autorzy:
Yuan Z; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, No. 507, Zhengmin Road, Yangpu District, Shanghai, 200433, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.
Wang Y; Department of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Yang Y; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, No. 507, Zhengmin Road, Yangpu District, Shanghai, 200433, China.
Qin X; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, No. 507, Zhengmin Road, Yangpu District, Shanghai, 200433, China. .
Pokaż więcej
Źródło:
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Jun 06; Vol. 19 (1), pp. 322. Date of Electronic Publication: 2024 Jun 06.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Lung Neoplasms*/metabolism
Cell Proliferation*/genetics
Cell Movement*/genetics
Proto-Oncogene Proteins c-akt*/metabolism
Proto-Oncogene Proteins c-akt*/genetics
Phosphatidylinositol 3-Kinases*/metabolism
Phosphatidylinositol 3-Kinases*/genetics
Signal Transduction*
Humans ; Cell Line, Tumor ; RNA Polymerase I/genetics ; RNA Polymerase I/metabolism ; Gene Expression Regulation, Neoplastic ; Gene Silencing
Czasopismo naukowe
Tytuł:
Aberrant lipid metabolism in pulmonary inflammation linked to lung cancer progression; a preliminary study.
Autorzy:
Lee D; Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea.; Multi-Omics Research Center, PURIMEDI Corp., Seoul, Republic of Korea.
Mun J; Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea.
Choi I; Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea.; Multi-Omics Research Center, PURIMEDI Corp., Seoul, Republic of Korea.
Joo J; Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea. .; Graduate School of Health Science and Technology, Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea. .; Center for Genomic Integrity, Institute for Basic Science, Ulsan, Republic of Korea. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Jun 06; Vol. 22 (1), pp. 542. Date of Electronic Publication: 2024 Jun 06.
Typ publikacji:
Letter
MeSH Terms:
Lung Neoplasms*/pathology
Lung Neoplasms*/metabolism
Lipid Metabolism*
Disease Progression*
Pneumonia*/metabolism
Pneumonia*/pathology
Pneumonia*/complications
Humans
Opinia redakcyjna
Tytuł:
Predicting treatment response in multicenter non-small cell lung cancer patients based on federated learning.
Autorzy:
Liu Y; School of Radiology, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Huang J; Department of Radiology, Cathay General Hospital, Taipei, China.; Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming Chiao- Tung University, Taipei, China.
Chen JC; Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming Chiao- Tung University, Taipei, China.; Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung, China.
Chen W; School of Radiology, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Pan Y; School of Radiology, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Qiu J; School of Radiology, Second Affiliated Hospital of Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jun 05; Vol. 24 (1), pp. 688. Date of Electronic Publication: 2024 Jun 05.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/therapy
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/therapy
Lung Neoplasms*/pathology
Lung Neoplasms*/radiotherapy
Humans ; Retrospective Studies ; Female ; Male ; Middle Aged ; Deep Learning ; Aged ; Machine Learning ; Tomography, X-Ray Computed ; Treatment Outcome ; Chemoradiotherapy/methods
Czasopismo naukowe
Tytuł:
Heterogeneity in PD-L1 expression between primary and metastatic lymph nodes: a predictor of EGFR-TKI therapy response in non-small cell lung cancer.
Autorzy:
Hu Y; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Huaihai West Road No.241, Shanghai, 200030, China.
Zhang Y; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Huaihai West Road No.241, Shanghai, 200030, China.
Lu Y; Department of Respiratory Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Yanchang Middle Road No.301, Shanghai, 200072, China.
Xu Y; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Huaihai West Road No.241, Shanghai, 200030, China.
Xu J; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Huaihai West Road No.241, Shanghai, 200030, China.
Zhong H; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Huaihai West Road No.241, Shanghai, 200030, China.
Cheng L; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Huaihai West Road No.241, Shanghai, 200030, China. .
Zhong R; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Huaihai West Road No.241, Shanghai, 200030, China. tonic_.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2024 Jun 05; Vol. 25 (1), pp. 233. Date of Electronic Publication: 2024 Jun 05.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/pathology
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/metabolism
B7-H1 Antigen*/biosynthesis
B7-H1 Antigen*/antagonists & inhibitors
B7-H1 Antigen*/metabolism
Lung Neoplasms*/drug therapy
Lung Neoplasms*/pathology
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
ErbB Receptors*/biosynthesis
ErbB Receptors*/genetics
ErbB Receptors*/metabolism
ErbB Receptors*/antagonists & inhibitors
Protein Kinase Inhibitors*/therapeutic use
Lymphatic Metastasis*
Humans ; Female ; Male ; Middle Aged ; Aged ; Retrospective Studies ; Lymph Nodes/pathology ; Lymph Nodes/drug effects ; Lymph Nodes/metabolism ; Adult ; Aged, 80 and over ; Treatment Outcome ; Predictive Value of Tests ; Mutation ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/biosynthesis ; Biomarkers, Tumor/metabolism ; Biomarkers, Tumor/analysis
Czasopismo naukowe
Tytuł:
Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma.
Autorzy:
Zhao J; Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong University, No.20 XISI road, ChongChuan District, NanTong, 226001, Jiangsu, China.; Medical School of Nantong University, Nantong University, ChongChuan District, NanTong, 226001, Jiangsu, China.
Lu Y; Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong University, No.20 XISI road, ChongChuan District, NanTong, 226001, Jiangsu, China.; Medical School of Nantong University, Nantong University, ChongChuan District, NanTong, 226001, Jiangsu, China.
Ren X; Department of Academic Development, Shanghai methyldia technology Co. Ltd, No. 412 Huiqing Road , Shanghai, 201203, China.
Bian T; Department of Pathology, Affiliated Hospital of Nantong University, Nantong University, No.20 XISI road, ChongChuan District, NanTong, 226001, Jiangsu, China.
Feng J; Department of Pathology, Affiliated Hospital of Nantong University, Nantong University, No.20 XISI road, ChongChuan District, NanTong, 226001, Jiangsu, China.
Sun H; Department of Pathology, Affiliated Hospital of Nantong University, Nantong University, No.20 XISI road, ChongChuan District, NanTong, 226001, Jiangsu, China.
Liu L; Department of Pathology, Affiliated Hospital of Nantong University, Nantong University, No.20 XISI road, ChongChuan District, NanTong, 226001, Jiangsu, China.
She B; Department of Academic Development, Shanghai methyldia technology Co. Ltd, No. 412 Huiqing Road , Shanghai, 201203, China.; Department of Pathology, Affiliated Hospital of Nantong University, Nantong University, No.20 XISI road, ChongChuan District, NanTong, 226001, Jiangsu, China.; Tellgen Corporation Co. Ltd, No. 115, Lane 572, Bibo Road, Pilot Free Trade Zone, Shanghai, 201203, China.
Liu Y; Department of Pathology, Affiliated Hospital of Nantong University, Nantong University, No.20 XISI road, ChongChuan District, NanTong, 226001, Jiangsu, China. .
Ke H; Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong University, No.20 XISI road, ChongChuan District, NanTong, 226001, Jiangsu, China. tranquillity_.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jun 05; Vol. 24 (1), pp. 687. Date of Electronic Publication: 2024 Jun 05.
Typ publikacji:
Journal Article
MeSH Terms:
Tumor Suppressor Proteins*/genetics
DNA Methylation*
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Homeodomain Proteins*/genetics
Neoplasm Staging*
Biomarkers, Tumor*/genetics
Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; ROC Curve
Czasopismo naukowe
Tytuł:
Clinicopathological and prognostic implications of EGFR mutations subtypes in Moroccan non-small cell lung cancer patients: A first report.
Autorzy:
Boukansa S; Laboratory of Biomedical and Translational Research, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdellah University, Fez, Morocco.; Laboratory of Anatomic Pathology and Molecular Pathology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Mouhrach I; Unit of Medical Genetics and Oncogenetics, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
El Agy F; Laboratory of Biomedical and Translational Research, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdellah University, Fez, Morocco.; Laboratory of Anatomic Pathology and Molecular Pathology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
El Bardai S; Laboratory of Anatomic Pathology and Molecular Pathology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Bouguenouch L; Unit of Medical Genetics and Oncogenetics, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Serraj M; Department of Pneumology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Amara B; Department of Pneumology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Ouadnouni Y; Department of Thoracic Surgery, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Smahi M; Department of Thoracic Surgery, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Alami B; Department of Radiology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Mellas N; Department of Oncology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Benbrahim Z; Department of Oncology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
El Fatemi H; Laboratory of Biomedical and Translational Research, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdellah University, Fez, Morocco.; Laboratory of Anatomic Pathology and Molecular Pathology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jun 05; Vol. 19 (6), pp. e0298721. Date of Electronic Publication: 2024 Jun 05 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/mortality
ErbB Receptors*/genetics
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/mortality
Mutation*
Humans ; Female ; Male ; Middle Aged ; Morocco/epidemiology ; Prognosis ; Aged ; Adult ; Prospective Studies ; Aged, 80 and over
Czasopismo naukowe
Tytuł:
Time-dependent efficacy analysis of first-line immunotherapies for advanced non-small cell lung cancer.
Autorzy:
Hui W; Department of Science and Techonology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Li W; Department of Health Service Management, School of Health Management, China Medical University, Shenyang, 110122, China.
Song R; School of Public Health, China Medical University, Shenyang, 110122, China.
Xin Y; Department of Science and Techonology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Wu C; Department of Health Service Management, School of Health Management, China Medical University, Shenyang, 110122, China.
Gao Z; Department of Pharmacy, Affiliated Central Hospital of Shenyang Medical College, Shenyang, 110024, China.
Zhang M; Department of Health Economics, School of Health Management, China Medical University, Shenyang, 110122, China.
Wu H; School of Medical Humanities, China Medical University, Shenyang, 110122, China.
Zhu M; Department of Health Service Management, School of Health Management, China Medical University, Shenyang, 110122, China. .
Cai Y; Department of Health Service Management, School of Health Management, China Medical University, Shenyang, 110122, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jun 05; Vol. 24 (1), pp. 684. Date of Electronic Publication: 2024 Jun 05.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/therapy
Carcinoma, Non-Small-Cell Lung*/mortality
Carcinoma, Non-Small-Cell Lung*/immunology
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/therapy
Lung Neoplasms*/mortality
Lung Neoplasms*/immunology
Lung Neoplasms*/pathology
Immunotherapy*/methods
Humans ; Time Factors ; Progression-Free Survival ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Female ; Male ; Nivolumab/therapeutic use ; Ipilimumab/therapeutic use ; Ipilimumab/administration & dosage ; Antibodies, Monoclonal, Humanized/therapeutic use ; Treatment Outcome ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
MNT inhibits lung adenocarcinoma ferroptosis and chemosensitivity by suppressing SAT1.
Autorzy:
Zhao G; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Liang J; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhang Y; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Shan G; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Bian Y; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Gu J; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhan C; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. .
Ge D; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2024 Jun 03; Vol. 7 (1), pp. 680. Date of Electronic Publication: 2024 Jun 03.
Typ publikacji:
Journal Article
MeSH Terms:
Ferroptosis*/genetics
Ferroptosis*/drug effects
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Lung Neoplasms*/pathology
Lung Neoplasms*/drug therapy
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Adenocarcinoma of Lung*/metabolism
Adenocarcinoma of Lung*/drug therapy
Acetyltransferases*/genetics
Acetyltransferases*/metabolism
Humans ; Mice ; Cell Line, Tumor ; Animals ; Drug Resistance, Neoplasm/genetics ; Mice, Nude ; Gene Expression Regulation, Neoplastic ; Cell Proliferation ; Antineoplastic Agents/pharmacology ; Xenograft Model Antitumor Assays ; Female ; Mice, Inbred BALB C ; Male
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies